{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:35:34Z","timestamp":1792794934849,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008021","name":"Fujian University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20408"],"award-info":[{"award-number":["U20A20408"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074450"],"award-info":[{"award-number":["82074450"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.phymed.2024.155554","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T12:36:22Z","timestamp":1711715782000},"page":"155554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Nanodelivery system of traditional Chinese medicine bioactive compounds: Application in the treatment of prostate cancer"],"prefix":"10.1016","volume":"135","author":[{"given":"Bo","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruisong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2024.155554_bib0001","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.biopha.2017.10.027","article-title":"Oleanolic acid methyl ester, a novel cytotoxic mitocan, induces cell cycle arrest and ROS-Mediated cell death in castration-resistant prostate cancer PC-3 cells","volume":"96","author":"Abdelmageed","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.phymed.2024.155554_bib0002","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1021\/jf305143k","article-title":"Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity","volume":"61","author":"Aditya","year":"2013","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"10.1016\/j.phymed.2024.155554_bib0003","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/jcp.29126","article-title":"Nanoparticles and cancer therapy: perspectives for application of nanoparticles in the treatment of cancers","volume":"235","author":"Aghebati-Maleki","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.phymed.2024.155554_bib0004","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3390\/molecules23092157","article-title":"Enhancing the delivery of chemotherapeutics: role of biodegradable polymeric nanoparticles","volume":"23","author":"Ahlawat","year":"2018","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.phymed.2024.155554_bib0005","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1080\/1061186X.2018.1527337","article-title":"Liposome: composition, characterisation, preparation, and recent innovation in clinical applications","volume":"27","author":"Ahmed","year":"2019","journal-title":"J. Drug Target"},{"issue":"8","key":"10.1016\/j.phymed.2024.155554_bib0006","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s13346-021-01095-1","article-title":"In vivo evaluation of nanostructured lipid carrier systems (NLCs) in mice bearing prostate cancer tumours","volume":"13","author":"Akanda","year":"2023","journal-title":"Drug Deliv. Transl. Res"},{"key":"10.1016\/j.phymed.2024.155554_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112609","article-title":"Recent developments of gallic acid derivatives and their hybrids in medicinal chemistry: a review","volume":"204","author":"Al Zahrani","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.phymed.2024.155554_bib0008","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/pharmaceutics15031025","article-title":"Nanotechnology in cancer diagnosis and treatment","volume":"15","author":"Alrushaid","year":"2023","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.phymed.2024.155554_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106052","article-title":"Functionalized niosomes as a smart delivery device in cancer and fungal infection","volume":"168","author":"Aparajay","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.phymed.2024.155554_bib0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/10408444.2020.1719974","article-title":"Toxicological profile of lipid-based nanostructures: are they considered as completely safe nanocarriers","volume":"50","author":"Azarnezhad","year":"2020","journal-title":"Crit. Rev. Toxicol."},{"issue":"13","key":"10.1016\/j.phymed.2024.155554_bib0011","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.3390\/ijms22137013","article-title":"Dextran-Curcumin Nanosystems inhibit cell growth and migration regulating the epithelial to Mesenchymal transition in prostate cancer cells","volume":"22","author":"Bevacqua","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.phymed.2024.155554_bib0012","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3390\/molecules26113374","article-title":"Diversity in chemical structures and biological properties of plant alkaloids","volume":"26","author":"Bhambhani","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2024.155554_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154306","article-title":"Role of curcumin in the treatment of acute kidney injury: research challenges and opportunities","volume":"104","author":"Cai","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2024.155554_bib0014","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/467147","article-title":"Preparation, physicochemical characterization, and cell viability evaluation of long-circulating and pH-sensitive liposomes containing ursolic acid","author":"Caldeira de Ara\u00fajo Lopes","year":"2013","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/j.phymed.2024.155554_bib0015","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00280-017-3301-1","article-title":"Curcumin inhibits prostate cancer by targeting PGK1 in the FOXD3\/miR-143 axis","volume":"79","author":"Cao","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155554_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153514","article-title":"Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity","volume":"85","author":"Chen","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2024.155554_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154534","article-title":"The safety of Chinese medicine: a systematic review of endogenous substances and exogenous residues","volume":"108","author":"Chen","year":"2023","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.phymed.2024.155554_bib0019","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-021-01096-0","article-title":"Nanomaterials for cancer therapy: current progress and perspectives","volume":"14","author":"Cheng","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.phymed.2024.155554_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021680","article-title":"The involvement of natural polyphenols in molecular mechanisms inducing apoptosis in tumor cells: a promising adjuvant in cancer therapy","volume":"24","author":"Chimento","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phymed.2024.155554_bib0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/pcan.2013.38","article-title":"Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo","volume":"16","author":"Chiu","year":"2013","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"6","key":"10.1016\/j.phymed.2024.155554_bib0021","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/pros.23766","article-title":"A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation","volume":"79","author":"Choi","year":"2019","journal-title":"Prostate"},{"issue":"11","key":"10.1016\/j.phymed.2024.155554_bib0022","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.3390\/molecules27113460","article-title":"A mini-review on solid lipid nanoparticles and nanostructured lipid carriers: topical delivery of phytochemicals for the treatment of acne vulgaris","volume":"27","author":"Chutoprapat","year":"2022","journal-title":"Molecules"},{"issue":"45","key":"10.1016\/j.phymed.2024.155554_bib0023","doi-asserted-by":"crossref","first-page":"26777","DOI":"10.1039\/D0RA03491F","article-title":"A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems","volume":"10","author":"Duan","year":"2020","journal-title":"RSC Adv."},{"issue":"9","key":"10.1016\/j.phymed.2024.155554_bib0024","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jsps.2021.07.015","article-title":"Nanostructured lipid carriers (NLCs) as drug delivery platform: advances in formulation and delivery strategies","volume":"29","author":"Elmowafy","year":"2021","journal-title":"Saudi Pharm. J."},{"issue":"4","key":"10.1016\/j.phymed.2024.155554_bib0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.prnil.2017.11.001","article-title":"Naringin sensitizes human prostate cancer cells to paclitaxel therapy","volume":"6","author":"Erdogan","year":"2018","journal-title":"Prostate Int."},{"issue":"4","key":"10.1016\/j.phymed.2024.155554_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11041201","article-title":"Design of chitosan-coated, quercetin-loaded PLGA nanoparticles for enhanced PSMA-specific activity on LnCap prostate cancer cells","volume":"11","author":"Essa","year":"2023","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.phymed.2024.155554_bib0027","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0022-5347(05)67685-9","article-title":"A blood-prostate barrier restricts cell and molecular movement across the rat ventral prostate epithelium","volume":"163","author":"Fulmer","year":"2000","journal-title":"J. Urol."},{"issue":"12","key":"10.1016\/j.phymed.2024.155554_bib0029","doi-asserted-by":"crossref","first-page":"10094","DOI":"10.3390\/ijms241210094","article-title":"Cdk4 regulates glioblastoma cell invasion and Stemness and is target of a Notch inhibitor plus resveratrol combined treatment","volume":"24","author":"Giordano","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.phymed.2024.155554_bib0030","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ijc.25678","article-title":"Bioactive tanshinones in Salvia miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in mice","volume":"129","author":"Gong","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"16","key":"10.1016\/j.phymed.2024.155554_bib0031","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1055\/s-0030-1249980","article-title":"Effects of Curcuma extracts and curcuminoids on expression of P-glycoprotein and cytochrome P450 3A4 in the intestinal cell culture model LS180","volume":"76","author":"Graber-Maier","year":"2010","journal-title":"Planta Med."},{"key":"10.1016\/j.phymed.2024.155554_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-56153-6_1","article-title":"Research in the middle east into the health benefits of Curcumin","volume":"1291","author":"Guest","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phymed.2024.155554_bib0033","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3389\/fbioe.2020.00879","article-title":"Enhancing bioavailability and stability of curcumin using solid lipid nanoparticles (CLEN): a covenant for its effectiveness","volume":"8","author":"Gupta","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"2","key":"10.1016\/j.phymed.2024.155554_bib0034","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.amjmed.2022.09.026","article-title":"Liver INJURY ASSOCIATED WITH TURMERIC-A GROWING PROBLEm: ten cases from the drug-induced liver injury network [DILIN]","volume":"136","author":"E-Halegoua-DeMarzio","year":"2023","journal-title":"Am. J. Med."},{"key":"10.1016\/j.phymed.2024.155554_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.582861","article-title":"Virtual screening and bioactivity evaluation of novel androgen receptor antagonists from Anti-PCa traditional chinese medicine prescriptions","volume":"8","author":"Han","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.phymed.2024.155554_bib0036","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.biopha.2016.09.046","article-title":"The reduction of IL-6 gene expression, pAKT, pERK1\/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells","volume":"84","author":"Heidarian","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2024.155554_bib0037","article-title":"Research and development of natural product Tanshinone I: pharmacology, total synthesis, and structure modifications","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155554_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108444","article-title":"Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression","volume":"84","author":"Jang","year":"2020","journal-title":"J. Nutr. Biochem."},{"issue":"2","key":"10.1016\/j.phymed.2024.155554_bib0040","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3390\/ijms24021186","article-title":"Inhibition of ANO1 by Cis- and trans-resveratrol and their anticancer activity in human prostate cancer PC-3 cells","volume":"24","author":"Jeon","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.phymed.2024.155554_bib0041","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/febs.16676","article-title":"Ginsenoside compound K suppresses tumour growth in the 22RV1 xenograft model and inhibits androgenic responses via the transcriptional mechanism in human prostate cancer cells","volume":"290","author":"Jiang","year":"2023","journal-title":"FEBS J."},{"issue":"7","key":"10.1016\/j.phymed.2024.155554_bib0042","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11655-021-3345-2","article-title":"Gallic acid: a potential anti-cancer agent","volume":"28","author":"Jiang","year":"2022","journal-title":"Chin. J. Integr. Med"},{"issue":"17","key":"10.1016\/j.phymed.2024.155554_bib0043","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.2174\/1389557521666210122153823","article-title":"Curcumin: an insight into molecular pathways involved in anticancer activity","volume":"21","author":"Joshi","year":"2021","journal-title":"Mini Rev. Med. Chem."},{"issue":"5","key":"10.1016\/j.phymed.2024.155554_bib0044","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.3892\/or.2016.4649","article-title":"Tetrandrine suppresses metastatic phenotype of prostate cancer cells by regulating Akt\/mTOR\/MMP-9 signaling pathway","volume":"35","author":"Kou","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phymed.2024.155554_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152962","article-title":"Antitumor activity of an Artemisia annua herbal preparation and identification of active ingredients","volume":"62","author":"Lang","year":"2019","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.phymed.2024.155554_bib0046","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2019020396","article-title":"Solid lipid nanoparticles: vital characteristics and prospective applications in cancer treatment","volume":"36","author":"Laz\u0103r","year":"2019","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.phymed.2024.155554_bib0047","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8859181","article-title":"Curcumin targets both apoptosis and Necroptosis in acidity-tolerant prostate carcinoma cells","volume":"2021","author":"Lee","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.phymed.2024.155554_bib0048","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4399334","article-title":"Evodiamine as the active compound of evodiae fructus to inhibit proliferation and migration of prostate cancer through PI3K\/AKT\/NF-\u03baB signaling pathway","volume":"2022","author":"Lei","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.phymed.2024.155554_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100704","article-title":"Nanomedicine to target multidrug resistant tumors","volume":"52","author":"Lepeltier","year":"2020","journal-title":"Drug Resist. Updat."},{"issue":"1","key":"10.1016\/j.phymed.2024.155554_bib0050","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1080\/10717544.2022.2094498","article-title":"Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review","volume":"29","author":"Li","year":"2022","journal-title":"Drug Deliv."},{"issue":"5","key":"10.1016\/j.phymed.2024.155554_bib0052","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s11427-016-9050-6","article-title":"Regulatory effects of antitumor agent matrine on FOXO and PI3K-AKT pathway in castration-resistant prostate cancer cells","volume":"61","author":"Li","year":"2018","journal-title":"Sci. China Life Sci"},{"issue":"1","key":"10.1016\/j.phymed.2024.155554_bib0053","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mc.23365","article-title":"Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment\/prevention of human prostate cancer","volume":"61","author":"Li","year":"2022","journal-title":"Mol. Carcinog."},{"issue":"17","key":"10.1016\/j.phymed.2024.155554_bib0054","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.3390\/molecules27175594","article-title":"Molecular mechanism of Tanshinone against prostate cancer","volume":"27","author":"Li","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.phymed.2024.155554_bib0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/acs.chemrestox.7b00248","article-title":"Curcumin derivative epigenetically reactivates Nrf2 Antioxidative stress signaling in mouse prostate cancer TRAMP C1 cells","volume":"31","author":"Li","year":"2018","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.phymed.2024.155554_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114056","article-title":"Transcriptional cyclin-dependent kinases: potential drug targets in cancer therapy","volume":"229","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phymed.2024.155554_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215927","article-title":"Prostate cancer treatment - China's perspective","volume":"550","author":"Liu","year":"2022","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.phymed.2024.155554_bib0060","doi-asserted-by":"crossref","first-page":"e12894","DOI":"10.1111\/cpr.12894","article-title":"Cellular senescence and cancer: focusing on traditional Chinese medicine and natural products","volume":"53","author":"Liu","year":"2020","journal-title":"Cell Prolif."},{"issue":"1","key":"10.1016\/j.phymed.2024.155554_bib0061","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41698-017-0027-9","article-title":"Erratum: combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism","volume":"1","author":"Lodi","year":"2017","journal-title":"NPJ Precis. Oncol"},{"issue":"7","key":"10.1016\/j.phymed.2024.155554_bib0062","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.7150\/ijbs.41686","article-title":"Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K\/Akt signaling pathways","volume":"16","author":"Lu","year":"2020","journal-title":"Int. J. Biol. Sci"},{"issue":"1","key":"10.1016\/j.phymed.2024.155554_bib0063","first-page":"20","article-title":"Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy","volume":"10","author":"Ma","year":"2023","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.phymed.2024.155554_bib0064","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.2147\/DDDT.S210949","article-title":"Delivery of Curcumin Nanoliposomes using surface modified with CD133 Aptamers for prostate cancer","volume":"13","author":"Ma","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"issue":"4","key":"10.1016\/j.phymed.2024.155554_bib0065","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3390\/cancers13040882","article-title":"Shikonin reduces growth of Docetaxel-resistant prostate cancer cells mainly through Necroptosis","volume":"13","author":"Markowitsch","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phymed.2024.155554_bib0066","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jconrel.2021.05.032","article-title":"Solid lipid nanoparticles for hydrophilic drugs","volume":"335","author":"Mirchandani","year":"2021","journal-title":"J. Control Rel."},{"issue":"3","key":"10.1016\/j.phymed.2024.155554_bib0067","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/jpet.121.000898","article-title":"The Andrographolide Analogue 3A.1 synergizes with Taxane derivatives in aggressive metastatic prostate cancers by Upregulation of heat shock proteins and Downregulation of MAT2A-mediated cell migration and invasion","volume":"380","author":"Mitra Ghosh","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.phymed.2024.155554_bib0068","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1124\/jpet.119.258012","article-title":"The interplay between blood proteins, complement, and macrophages on nanomedicine performance and responses","volume":"370","author":"Moghimi","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"10.1016\/j.phymed.2024.155554_bib0069","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12032-022-01836-3","article-title":"Niosomes: a novel targeted drug delivery system for cancer","volume":"39","author":"Moghtaderi","year":"2022","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.phymed.2024.155554_bib0070","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/ma15020682","article-title":"Synthesis and potential applications of lipid nanoparticles in medicine","volume":"15","author":"Musielak","year":"2022","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.phymed.2024.155554_bib0071","article-title":"The function of natural compounds in important anticancer mechanisms","volume":"12","author":"Nan","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.phymed.2024.155554_bib0072","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2010.06.006","article-title":"Cryptotanshinone sensitizes DU145 prostate cancer cells to Fas(APO1\/CD95)-mediated apoptosis through Bcl-2 and MAPK regulation","volume":"298","author":"Park","year":"2010","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.phymed.2024.155554_bib0073","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/pharmaceutics15020628","article-title":"Polymeric systems for the controlled release of flavonoids","volume":"15","author":"Pecorini","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.phymed.2024.155554_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175522","article-title":"Diosgenin inhibits prostate cancer progression by inducing UHRF1 protein degradation","volume":"942","author":"Peng","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155554_bib0076","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.chemphyslip.2016.05.006","article-title":"Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer","volume":"198","author":"Radhakrishnan","year":"2016","journal-title":"Chem. Phys. Lipids."},{"issue":"9","key":"10.1016\/j.phymed.2024.155554_bib0077","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0278-6915(01)00022-9","article-title":"Assessment of the no-observed-adverse-effect level (NOAEL) of gallic acid in mice","volume":"39","author":"Rajalakshmi","year":"2001","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phymed.2024.155554_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2021.101258","article-title":"Different nano-delivery systems for delivery of nutraceuticals","volume":"43","author":"Rashidi","year":"2021","journal-title":"Food Biosci."},{"key":"10.1016\/j.phymed.2024.155554_bib0078","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2020.07.002","article-title":"Liposomes: advancements and innovation in the manufacturing process","volume":"154-155","author":"Shah","year":"2020","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"6","key":"10.1016\/j.phymed.2024.155554_bib0079","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/02652048.2022.2135785","article-title":"Development, evaluation, pharmacokinetic and biodistribution estimation of resveratrol-loaded solid lipid nanoparticles for prostate cancer targeting","volume":"39","author":"Sharma","year":"2022","journal-title":"J. Microencapsul."},{"issue":"1","key":"10.1016\/j.phymed.2024.155554_bib0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2024.155554_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111035","article-title":"LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer","volume":"114","author":"Shitole","year":"2020","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"1","key":"10.1016\/j.phymed.2024.155554_bib0082","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408398.2014.971353","article-title":"A comprehensive overview on the micro- and nano-technological encapsulation advances for enhancing the chemical stability and bioavailability of carotenoids","volume":"58","author":"Soukoulis","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"1","key":"10.1016\/j.phymed.2024.155554_bib0083","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1080\/10717544.2021.1931559","article-title":"Combination prostate cancer therapy: prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone","volume":"28","author":"Sun","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.phymed.2024.155554_bib0084","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.949332","article-title":"Antitumor effects of Chinese herbal medicine compounds and their nano-formulations on regulating the immune system microenvironment","volume":"12","author":"Sun","year":"2022","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.phymed.2024.155554_bib0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/biomedicines8080253","article-title":"Curcumin nanoparticles and their cytotoxicity in docetaxel-resistant castration-resistant prostate cancer cells","volume":"8","author":"Tanaudommongkon","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.phymed.2024.155554_bib0086","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.2147\/IJN.S327045","article-title":"Bombesin peptide conjugated water-soluble chitosan Gallate-A new Nanopharmaceutical Architecture for the Rapid One-Pot synthesis of prostate tumor targeted gold nanoparticles","volume":"16","author":"Tangthong","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"11","key":"10.1016\/j.phymed.2024.155554_bib0087","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid Nanoparticles-from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.phymed.2024.155554_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111723","article-title":"PSMA conjugated combinatorial liposomal formulation encapsulating genistein and plumbagin to induce apoptosis in prostate cancer cells","volume":"203","author":"Tian","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"4","key":"10.1016\/j.phymed.2024.155554_bib0091","first-page":"1259","article-title":"Emodin: its role in prostate cancer\u2011associated inflammation (Review)","volume":"42","author":"Tu","year":"2019","journal-title":"Oncol. Rep."},{"issue":"7","key":"10.1016\/j.phymed.2024.155554_bib0092","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/pros.23317","article-title":"A placebo-controlled double-blinded randomized pilot study of combination Phytotherapy in biochemically recurrent prostate cancer","volume":"77","author":"van Die","year":"2017","journal-title":"Prostate."},{"issue":"14","key":"10.1016\/j.phymed.2024.155554_bib0093","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.3390\/nu15143136","article-title":"Recent progress in nanotechnology improving the therapeutic potential of polyphenols for cancer","volume":"15","author":"Vieira","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.phymed.2024.155554_bib0094","article-title":"Tumor immunomodulatory effects of polyphenols","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.phymed.2024.155554_bib0095","doi-asserted-by":"crossref","first-page":"550","DOI":"10.35516\/jjps.v16i3.1609","article-title":"Exploration of potentially bioactive compounds from Fingerroot (Boesenbergia rotunda L.) as inhibitor of atherosclerosis-related proteins (CETP, ACAT1, OSC, sPLA2): an in silico study","volume":"16","author":"Widyananda","year":"2023","journal-title":"Jordan J. Pharm. Sci"},{"issue":"3","key":"10.1016\/j.phymed.2024.155554_bib0096","doi-asserted-by":"crossref","DOI":"10.33640\/2405-609X.3312","article-title":"Quercetin as an anticancer candidate for glioblastoma multiforme by targeting AKT1, MMP9, ABCB1, and VEGFA: an in silico study","volume":"9","author":"Widyananda","year":"2023","journal-title":"Karbala Int. J. Modern Sci."},{"issue":"1","key":"10.1016\/j.phymed.2024.155554_bib0097","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12957-018-1400-z","article-title":"Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways","volume":"16","author":"Ward","year":"2018","journal-title":"World J. Surg. Oncol"},{"issue":"11","key":"10.1016\/j.phymed.2024.155554_bib0098","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/jpp\/rgab082","article-title":"Vesicular drug delivery for the treatment of topical disorders: current and future perspectives","volume":"73","author":"Witika","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"10.1016\/j.phymed.2024.155554_bib0099","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ptr.3616","article-title":"Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells","volume":"26","author":"Won","year":"2012","journal-title":"Phytother. Res."},{"issue":"4","key":"10.1016\/j.phymed.2024.155554_bib0100","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/cam4.1419","article-title":"Traditional Chinese medicine CFF-1 induced cell growth inhibition, autophagy, and apoptosis via inhibiting EGFR-related pathways in prostate cancer","volume":"7","author":"Wu","year":"2018","journal-title":"Cancer Med."},{"issue":"10","key":"10.1016\/j.phymed.2024.155554_bib0101","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101177","article-title":"Ultrasound-mediated microbubbles cavitation enhanced chemotherapy of advanced prostate cancer by increasing the permeability of blood-prostate barrier","volume":"14","author":"Xia","year":"2021","journal-title":"Transl. Oncol"},{"issue":"6","key":"10.1016\/j.phymed.2024.155554_bib0103","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/molecules24061123","article-title":"Antioxidant activities of Quercetin and its complexes for medicinal application","volume":"24","author":"Xu","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.phymed.2024.155554_bib0104","first-page":"3814","article-title":"Anticancer effect of miR-96 inhibitor in bladder cancer cell lines","volume":"15","author":"Xu","year":"2018","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.phymed.2024.155554_bib0105","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3109\/10717544.2015.1069423","article-title":"Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo","volume":"23","author":"Yan","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.phymed.2024.155554_bib0106","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2147\/DDDT.S126964","article-title":"Curcumin induces apoptosis and protective autophagy in castration-resistant prostate cancer cells through iron chelation","volume":"11","author":"Yang","year":"2017","journal-title":"Drug Des. Devel Ther."},{"issue":"2","key":"10.1016\/j.phymed.2024.155554_bib0107","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/apm.12650","article-title":"Curcumin inhibits the survival and metastasis of prostate cancer cells via the Notch-1 signaling pathway","volume":"125","author":"Yang","year":"2017","journal-title":"APMIS"},{"key":"10.1016\/j.phymed.2024.155554_bib0108","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121878","article-title":"A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system","volume":"624","author":"Yasamineh","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phymed.2024.155554_bib0109","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.895696","article-title":"Astragalus-scorpion drug pair inhibits the development of prostate cancer by regulating GDPD4-2\/PI3K\/AKT\/mTOR pathway and autophagy","volume":"13","author":"You","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155554_bib0110","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.2147\/DDDT.S261027","article-title":"Assessment of a new Ginsenoside Rh2 Nanoniosomal Formulation for enhanced antitumor efficacy on prostate cancer: an in vitro study","volume":"14","author":"Zare-Zardini","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.phymed.2024.155554_bib0111","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106199","article-title":"Co-delivery of Docetaxel and Resveratrol by liposomes synergistically boosts antitumor efficiency against prostate cancer","volume":"174","author":"Zhang","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.phymed.2024.155554_bib0112","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.nutres.2015.11.019","article-title":"Quercetin regulates hepatic cholesterol metabolism by promoting cholesterol-to-bile acid conversion and cholesterol efflux in rats","volume":"36","author":"Zhang","year":"2016","journal-title":"Nutr. Res."},{"key":"10.1016\/j.phymed.2024.155554_bib0113","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2147\/OTT.S228453","article-title":"Quercetin enhanced paclitaxel therapeutic effects towards PC-3 prostate cancer through ER stress induction and ROS production","volume":"13","author":"Zhang","year":"2020","journal-title":"Onco. Targets Ther"},{"issue":"26","key":"10.1016\/j.phymed.2024.155554_bib0114","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202300961","article-title":"Synthesis and application of fluorescent polymer Micro- and nanoparticles","volume":"19","author":"Zhong","year":"2023","journal-title":"Small"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324002198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324002198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T09:04:22Z","timestamp":1762333462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324002198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":106,"alternative-id":["S0944711324002198"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155554","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanodelivery system of traditional Chinese medicine bioactive compounds: Application in the treatment of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"155554"}}